Metaplanet
3350
Mitsubishi Heavy Industries
7011
Nippon Telegraph & Telephone
9432
4
Kioxia Holdings
285A
5
Sanrio
8136
JP Stock MarketDetailed Quotes
2395 Shin Nippon Biomedical Laboratories
- 1620
- -40-2.41%
20min DelayMarket Closed Feb 18 15:30 JST
67.44BMarket Cap12.19P/E (Static)
1668High1618Low232.30KVolume1668Open1660Pre Close379.42MTurnover189752wk High1.41%Turnover Ratio41.63MShares97052wk Low118.71EPS TTM26.74BFloat Cap3225Historical High12.19P/E (Static)16.51MShs Float185Historical Low132.86EPS LYR3.01%Amplitude50.00Dividend TTM1.50P/B100Lot Size3.09%Div YieldTTM
About Shin Nippon Biomedical Laboratories Company
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
Company Profile
Symbol2395
Company NameShin Nippon Biomedical Laboratories
Founded1973-05-18
MarketTSE Prime
Employees1451
Fiscal Year Ends03-31
Address8-1 Akashi-cho
Zip Code891-1394
Phone099-294-2600
Websitewww.snbl.co.jp
Company Executives
- Name
- Position
- Salary
- Dr. Ryoichi Nagata
- Chairman of the Board, President ,Chief Executive Officer, Chief Health Officer and Director of Fisheries Business
- --
- Ken Takanashi
- Director and Vice President
- --
- Dr. Ichiro Nagata
- Director and Executive Vice President
- --
- Dr. Hideshi Tsusaki
- Director and Senior Managing Director
- --
- Chizuru Matsueda
- Independent Director
- --
- Tsuyoshi Hanada
- Independent Director
- --
- Shinichi Fukumoto
- Independent Director
- --
- Keiko Toya
- Independent Director
- --
- Takashi Yamashita
- Independent Director
- --